nitric oxide for inhalation

DRUG4 trials

Sponsors

Mallinckrodt

Conditions

CardiomyopathyCystic FibrosisHypoxemiaIdiopathic Pulmonary Arterial HypertensionIschemia-Reperfusion InjuryLung DiseaseRespiratory Acidosis

Phase 1

Inhaled Nitric Oxide in Neonates With Elevated A-a DO2 Gradients Not Requiring Mechanical Ventilation

TerminatedNCT00041548

MallinckrodtHypoxemia, Lung Disease, Respiratory Acidosis

Start: 2002-05-31End: 2005-06-30Updated: 2016-10-19

Safety and Tolerability of Inhaled Nitric Oxide in Patients With Cystic Fibrosis

CompletedNCT00570349

MallinckrodtCystic Fibrosis

Start: 2004-07-31End: 2008-12-31Updated: 2019-11-13

Phase 3

Inhaled Nitric Oxide in Prevention/Treatment of Ischemia-Reperfusion Lung Injury Related to Lung Transplantation

TerminatedNCT00060450

MallinckrodtIschemia-Reperfusion Injury

Start: 2001-08-31End: 2006-09-30Updated: 2016-09-09

Comparison of Inhaled Nitric Oxide and Oxygen in Participants Reactivity During Acute Pulmonary Vasodilator Testing

CompletedNCT00626028

MallinckrodtCardiomyopathy, Idiopathic Pulmonary Arterial Hypertension

Start: 2004-09-30End: 2010-02-28Updated: 2019-12-20

Related Papers

Nitric oxide administration using an oxygen hood: a pilot trial.

2009-02-025 citations